亚历克西西米亚会降低刺激性肠综合征患者的生活质量
Mona Boudabbous1,2, Ala Ben Issa2, Ines Feki3,2
1Gastroenterology Department, Hédi Chaker Hospital, Sfax, TUNISIA.
Future science OA
|September 27, 2023
概括
一半的刺激性肠综合征 (IBS) 患者经历了alexithymia,显著影响了他们的生活质量. 这项研究强调了alexithymia和焦虑是导致IBS患者幸福感下降的关键因素.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 生活质量研究 研究 生命质量研究
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的胃肠疾病.
- 亚历克西西米亚,以难以识别和描述情绪为特征,在各种医疗条件中越来越多地被认可.
- 亚历克西西米亚,生活质量和IBS之间的相互作用需要进一步研究.
研究的目的:
- 为了比较IBS患者与对照者的alexithymia和生活质量损害的患病率.
- 为了确定与IBS中alexithymia相关的因素.
- 确定与IBS患者生活质量下降相关的因素.
主要方法:
- 一项涉及80名IBS患者和80名健康对照者的比较研究.
- 使用标准化诊断标准评估alexithymia的流行情况.
- 通过验证的问卷来评估生活质量.
主要成果:
- 在75%的IBS患者中,生活质量显著下降,而对照组中只有37.5% (p < 0.0001).
- 在IBS患者中,alexithymia的患病率明显高 (50%),而不是对照组 (1.2%) (p < 0.0001).
- 多变量分析显示,alexithymia (p = 0.003) 和焦虑与IBS患者的生活质量受损显著相关.
结论:
- 亚历克西西米亚在IBS患者中非常普遍,影响了大约一半的研究队列.
- 亚历克西西米亚是IBS患者生活质量下降的一个重要因素.
- 针对alexithymia和焦虑症可能对改善IBS管理中的生活质量至关重要.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
304
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
304
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
181
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
181
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
225
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
225
01:17Drugs for Treatment of Diarrhea-Predominant IBS
200
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
200
01:17Chronic Bowel Disorders: Introduction
474
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
474
01:21Drugs for Treatment of Constipation-Predominant IBS
197
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
197